Report - Jahresbericht 2014 - SAKK · Studie INOVATYON aktiviert Die Studie INOVATYON Phase III international, ran-domized study of trabectedin plus Pegylated Lipo-somal Doxorubicin (PLD)

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form